MyAverix Finance
NS · Healthcare
Vista Pharmaceuticals Ltd (524711)
Pharmaceuticals & Biotechnology
Vista Pharmaceuticals Ltd (524711) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $456.10M, P/E ratio is -3.78, net margin is -99.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 524711
Vista Pharmaceuticals Ltd (524711) — FAQ
What is Vista Pharmaceuticals Ltd's market cap?
Vista Pharmaceuticals Ltd (524711) has a reported market cap of $456.10M (data as of 2026-07-10).
What is 524711's P/E ratio?
The price-to-earnings (P/E) ratio for Vista Pharmaceuticals Ltd (524711) is -3.78 (data as of 2026-07-10).
Does Vista Pharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Vista Pharmaceuticals Ltd (524711). Check the MyAverix Finance app for the latest dividend data.
What sector is Vista Pharmaceuticals Ltd in?
Vista Pharmaceuticals Ltd (524711) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 524711 listed on?
524711 is listed on NS.
What is Vista Pharmaceuticals Ltd's net margin?
Vista Pharmaceuticals Ltd (524711) reports a net margin of -99.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.